The serine protease inhibitor of Kazal-type 7 (SPINK7) is expressed in human skin

Arch Dermatol Res. 2017 Nov;309(9):767-771. doi: 10.1007/s00403-017-1773-9. Epub 2017 Aug 29.

Abstract

Proteases and their inhibitors play an important role in epidermal homeostasis. Their imbalance contributes to severe skin diseases. SPINK7 is a member of the SPINK protease inhibitor family and has been described so far as a cancer-related gene in the esophagus. Herein, we describe for the first time its expression in healthy human skin. Moreover, SPINK7 is up-regulated in inflammatory skin diseases like psoriasis and eczema as demonstrated by immunohistochemistry, though real-time PCR analyses revealed no significant up-regulation. In cultured keratinocytes, SPINK7 mRNA expression was up-regulated by IL-17A together with IFNγ. Our observation points to a role of SPINK7 in skin homeostasis and its involvement in inflammatory skin diseases.

Keywords: Epidermis; Esophageal cancer-related gene; KLK; Kallikrein-related peptidase; LEKTI; Protease inhibitor; Psoriasis.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Eczema / metabolism
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Psoriasis / metabolism
  • Serine Peptidase Inhibitors, Kazal Type / analysis*
  • Serine Peptidase Inhibitors, Kazal Type / physiology
  • Skin / chemistry*
  • Young Adult

Substances

  • SPINK7 protein, human
  • Serine Peptidase Inhibitors, Kazal Type